DNAPrint Genomics, Inc.
DNAG
$0.00
$0.000.00%
OTC PK
| 09/30/2007 | 06/30/2007 | 03/31/2007 | 12/31/2006 | 09/30/2006 | |
|---|---|---|---|---|---|
| Revenue | -65.08% | -17.36% | 3.33% | 42.44% | 105.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -65.08% | -17.36% | 3.33% | 42.44% | 105.62% |
| Cost of Revenue | -45.99% | 6.51% | -3.47% | 16.69% | 77.05% |
| Gross Profit | -103.02% | -59.15% | 28.31% | 145.45% | 202.64% |
| SG&A Expenses | -45.68% | -33.00% | -33.41% | -29.13% | 16.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -44.09% | -19.01% | -34.25% | 20.29% | 92.28% |
| Operating Income | 39.08% | 19.53% | 44.11% | -14.89% | -89.36% |
| Income Before Tax | 43.67% | 28.63% | 204.26% | 4.27% | -135.29% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 43.67% | 28.63% | 204.26% | 4.27% | -135.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 43.67% | 28.63% | 204.26% | 4.27% | -135.29% |
| EBIT | 39.08% | 19.53% | 44.11% | -14.89% | -89.36% |
| EBITDA | 41.21% | 21.73% | 45.82% | -10.66% | -88.18% |
| EPS Basic | 64.71% | 55.22% | 159.18% | 58.41% | 52.51% |
| Normalized Basic EPS | 62.75% | 54.76% | 60.66% | 76.87% | 52.78% |
| EPS Diluted | 64.71% | 70.00% | 139.00% | 58.41% | 52.51% |
| Normalized Diluted EPS | 62.75% | 54.76% | 73.77% | 76.87% | 52.78% |
| Average Basic Shares Outstanding | 60.63% | 58.18% | 75.48% | 129.37% | 395.72% |
| Average Diluted Shares Outstanding | 60.63% | 58.18% | 159.40% | 129.37% | 395.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |